Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Supporters often emphasize the opportunity for substantial therapeutic gains, principally in conditions where conventional treatments have proven limited. However, this is to consider the considerable financial expenditure associated with CPI stem